Australia Traumatic Brain Injury Biomarkers Market Size & Outlook
Related Markets
Australia traumatic brain injury biomarkers market highlights
- The Australia traumatic brain injury biomarkers market generated a revenue of USD 33.4 million in 2024 and is expected to reach USD 161.8 million by 2033.
- The Australia market is expected to grow at a CAGR of 19.7% from 2025 to 2033.
- In terms of segment, protein biomarkers was the largest revenue generating type in 2024.
- Metabolomic biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
Traumatic brain injury biomarkers market data book summary
| Market revenue in 2024 | USD 33.4 million |
| Market revenue in 2033 | USD 161.8 million |
| Growth rate | 19.7% (CAGR from 2025 to 2033) |
| Largest segment | Protein biomarkers |
| Fastest growing segment | Metabolomic biomarkers |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Protein biomarkers, Genetic biomarkers, Metabolomic biomarkers |
Other key industry trends
- In terms of revenue, Australia accounted for 3.2% of the global traumatic brain injury biomarkers market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China traumatic brain injury biomarkers market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 105.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Traumatic Brain Injury Biomarkers Market Scope
Traumatic Brain Injury Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Brainbox Solutions | View profile | 1-10 | Drouin, Victoria, Australia, Oceania | http://brainboxsolutions.com.au |
| NeuroTrauma Sciences | View profile | 11-50 | Alpharetta, Georgia, United States, North America | http://neurotraumasciences.com/ |
| ImmunArray | View profile | 51-100 | Richmond, Virginia, United States, North America | http://www.immunarray.com/ |
| Banyan Biomarkers | View profile | 11-50 | Alachua, Florida, United States, North America | http://banyanbio.com |
| Randox Laboratories | View profile | - | - | - |
| QIAGEN N.V. | View profile | - | - | - |
| Quanterix | View profile | 251-500 | Billerica, Massachusetts, United States, North America | http://www.quanterix.com |
| Fujirebio Diagnostics | View profile | 5001-10000 | Malvern, Pennsylvania, United States, North America | http://www.fdi.com/ |
| Thermo Fisher Scientific Inc. | View profile | - | - | - |
| Koninklijke Philips N.V. | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| GE Healthcare | View profile | 10001+ | Chicago, Illinois, United States, North America | http://www.gehealthcare.com |
| Oculogica | View profile | 1-10 | New York, New York, United States, North America | http://www.oculogica.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
Australia traumatic brain injury biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to traumatic brain injury biomarkers market will help companies and investors design strategic landscapes.
Protein biomarkers was the largest segment with a revenue share of 63.77% in 2024. Horizon Databook has segmented the Australia traumatic brain injury biomarkers market based on protein biomarkers, genetic biomarkers, metabolomic biomarkers covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Australia traumatic brain injury biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia traumatic brain injury biomarkers market databook
-
Our clientele includes a mix of traumatic brain injury biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia traumatic brain injury biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Australia traumatic brain injury biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Australia traumatic brain injury biomarkers market size, by type, 2021-2033 (US$M)
Australia Traumatic Brain Injury Biomarkers Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
